O'SHAUGHNESSY ASSET MANAGEMENT, LLC

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1423442 Stamford, CT

Position in AUPH

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$9,630,339

+$3,494,578 QoQ

Shares Held

567,492

+37.1% QoQ

Ownership

0.427%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#24

of 279 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

O'SHAUGHNESSY ASSET MANAGEMENT, LLC holds $102,425,978 across 44 Biotechnology names. AUPH ranks #2 (9.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	42,063	$20,893,953
2	AUPH	Aurinia Pharmaceuticals Inc. This page	567,492	$9,630,339
3	PBYI	Puma Biotechnology, Inc.	1,123,783	$9,113,880
4	EXEL	Exelixis, Inc.	124,709	$6,785,416
5	JAZZ	Jazz Pharmaceuticals plc	25,864	$6,232,448
6	ARGX	Argenx SE	6,450	$5,984,116
7	REGN	Regeneron Pharmaceuticals, Inc.	9,404	$5,863,770
8	RIGL	Rigel Pharmaceuticals Inc	131,177	$5,131,644

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,630,339	567,492	+37.1%	Shares	Sole	2026-08-13
2026-03-31	$6,135,761	414,019	+7.0%	Shares	Sole	2026-05-13
2025-12-31	$6,170,161	386,844	+191.9%	Shares	Sole	2026-02-11
2025-09-30	$1,464,533	132,537	+530.5%	Shares	Sole	2025-11-13
2025-06-30	$178,047	21,021	+2.1%	Shares	Sole	2025-08-12
2025-03-31	$165,543	20,590	+41.3%	Shares	Sole	2025-05-13
2024-12-31	$130,856	14,572	+2.1%	Shares	Sole	2025-02-12
2024-09-30	$104,628	14,274	—	Shares	Sole	2024-11-12
No filing history on record for this holder in this stock.